Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015;67(3):519–30.

PubMed  Article  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.

PubMed  Article  Google Scholar 

Malouf GG, Su X, Zhang J, Creighton CJ, Ho TH, Lu Y, Raynal NJ, Karam JA, Tamboli P, Allanick F, et al. DNA methylation signature reveals cell ontogeny of renal cell carcinoma. Clin Cancer Res. 2016;22(24):6236–46.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135–45.

PubMed  Article  CAS  Google Scholar 

Tachibana H, Kondo T, Ishihara H, Fukuda H, Yoshida K, Takagi T, Izuka J, Kobayashi H, Tanabe K. Modest efficacy of nivolumab plus ipilimumab in patients with papillary renal cell carcinoma. Jpn J Clin Oncol. 2021;51(4):646–53.

PubMed  Article  Google Scholar 

Chen Q, Cheng L, Li Q. The molecular characterization and therapeutic strategies of papillary renal cell carcinoma. Expert Rev Anticancer Ther. 2019;19(2):169–75.

CAS  PubMed  Article  Google Scholar 

Courthod G, Tucci M, Di Maio M, Scagliotti GV. Papillary renal cell carcinoma: a review of the current therapeutic landscape. Crit Rev Oncol Hematol. 2015;96(1):100–12.

PubMed  Article  Google Scholar 

Eich ML, Chaux A, Mendoza RM, Guner G, Taheri D, Rodriguez PM, Sharma R, Allaf ME, Netto GJ. Tumor immune microenvironment in primary and metastatic papillary renal cell carcinoma. Histopathology. 2020;76(3):423–32.

PubMed  Article  Google Scholar 

Cao H, Zhang J, Wang W. DAB2IP plays important clinical significance and correlates with immune infiltration in renal cell carcinoma. Technol Cancer Res Treat. 2020;19:1079204330.

Google Scholar 

Wang R, Xing R, Su Q, Yin H, Wu D, Lv C, Yan Z. Knockdown of SFRS9 inhibits progression of colorectal cancer through triggering ferroptosis mediated by GPX4 reduction. Front Oncol. 2021;11:683589.

PubMed  PubMed Central  Article  Google Scholar 

Chaudhary N, Choudhary BS, Shah SG, Khapare N, Dwivedi N, Gaikwad A, Joshi N, Raichanna J, Basu S, Gurjar M, et al. Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer. Int J Cancer. 2021;149(7):1495–511.

CAS  PubMed  Article  Google Scholar 

Wang H, Zhu Y, Chen H, Yang N, Wang X, Li B, Ying P, He H, Cai Y, Zhang M, et al. Colorectal cancer risk variant rs7017386 modulates two oncogenic lncRNAs expression via ATF1-mediated long-range chromatin loop. Cancer Lett. 2021;518:140–51.

CAS  PubMed  Article  Google Scholar 

Yuan MX, Ji CY, Gao HQ, Sheng XY, Xie WX, Yin Q. lncRNA TUG1 regulates angiogenesis via the miR2045p/JAK2/STAT3 axis in hepatoblastoma. Mol Med Rep. 2021;24(2):1–9.

Article  CAS  Google Scholar 

Su Z, Chen M, Ding R, Shui L, Zhao Q, Luo W. Long noncoding RNA HCG11 suppresses the malignant phenotype of non-small cell lung cancer cells by targeting the miR875/SATB2 axis. Mol Med Rep. 2021;24(2):1–11.

Article  CAS  Google Scholar 

Liu Y, Zhou P, Wang F, Zhang X, Yang D, Hong L, Ruan D. Inhibition of lncRNA SNHG8 plays an important role in hypoxia-ischemia-reoxygenation-induced myocardial injury by regulating miR-335 and RASA1 expressions. Mol Med Rep. 2021;24(2):1–9.

Google Scholar 

Liu K, Chen S, Lu R. Identification of important genes related to ferroptosis and hypoxia in acute myocardial infarction based on WGCNA. Bioengineered. 2021;12(1):7950–63.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Dietrich C, Hofmann TG. Ferroptosis meets cell–cell contacts. Cells (Basel). 2021;10(9):2462.

CAS  Google Scholar 

Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G. Ferroptosis: past, present, and future. Cell Death Dis. 2020;11(2):88.

PubMed  PubMed Central  Article  Google Scholar 

Wu C, Liu Z, Chen Z, Xu D, Chen L, Lin H, Shi J. A Nonferrous ferroptosis-like strategy for antioxidant inhibition-synergized nanocatalytic tumor therapeutics. Sci Adv. 2021;7(39):j8833.

Article  CAS  Google Scholar 

Emmons MF, Smalley K. Ironing-out the details: new strategies for combining ferroptosis inhibitors with immunotherapy in melanoma. J Investig Dermatol. 2022;142(1):18–20.

CAS  PubMed  Article  Google Scholar 

Liu M, Wang L, Xia X, Wu Y, Zhu C, Duan M, Wei X, Hu J, Lei L. Regulated lytic cell death in breast cancer. Cell Biol Int. 2022;46(1):12–33.

PubMed  Article  Google Scholar 

Zhao E, Chen S, Dang Y. Development and external validation of a novel immune checkpoint-related gene signature for prediction of overall survival in hepatocellular carcinoma. Front Mol Biosci. 2020;7:620765.

CAS  PubMed  Article  Google Scholar 

Tang Y, Li C, Zhang YJ, Wu ZH. Ferroptosis-related long non-coding RNA signature predicts the prognosis of head and neck squamous cell carcinoma. Int J Biol Sci. 2021;17(3):702–11.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wang Z, Jensen MA, Zenklusen JC. A practical guide to the Cancer Genome Atlas (TCGA). Methods Mol Biol. 2016;1418:111–41.

PubMed  Article  Google Scholar 

Zhou N, Bao J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database (Oxford). 2020. https://doi.org/10.1093/database/baaa021.

Article  PubMed Central  Google Scholar 

Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, et al. STRING v9.1: protein–protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41(Database issue):D808–15.

CAS  PubMed  Google Scholar 

Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, Hackl H, Trajanoski Z. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248–62.

CAS  PubMed  Article  Google Scholar 

Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, Trevino V, Shen H, Laird PW, Levine DA, et al. Inferring tumor purity, stromal, and immune cell admixture from expression data. Nat Commun. 2013;4:2612.

PubMed  Article  CAS  Google Scholar 

Shi J, Jiang D, Yang S, Zhang X, Wang J, Liu Y, Sun Y, Lu Y, Yang K. LPAR1, correlated with immune infiltrates, is a potential prognostic biomarker in prostate cancer. Front Oncol. 2020;10:846.

PubMed  PubMed Central  Article  Google Scholar 

Yi M, Nissley DV, McCormick F, Stephens RM. ssGSEA score-based ras dependency indexes derived from gene expression data reveal potential ras addiction mechanisms with possible clinical implications. Sci Rep. 2020;10(1):10258.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Can Res. 2017;77(21):e108–10.

CAS  Article  Google Scholar 

Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 2020;5(1):22.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Yang WS, Stockwell BR. Ferroptosis death by lipid peroxidation. Trends Cell Biol. 2016;26(3):165–76.

CAS  PubMed  Article  Google Scholar 

Friedmann AJ, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch A, Eggenhofer E, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180–91.

Article  CAS  Google Scholar 

Stockwell BR, Friedmann AJ, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascon S, Hatzios SK, Kagan VE, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273–85.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Yang WH, Ding CC, Sun T, Rupprecht G, Lin CC, Hsu D, Chi JT. The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma. Cell Rep. 2019;28(10):2501–8.

CAS  PubMed  Article  Google Scholar 

Markowitsch SD, Schupp P, Lauckner J, Vakhrusheva O, Slade KS, Mager R, Efferth T, Haferkamp A, Juengel E. Artesunate inhibits growth of sunitinib-resistant renal cell carcinoma through cell cycle arrest and induction of ferroptosis. Cancers (Basel). 2020;12(11):3150.

CAS  Article  Google Scholar 

Lei G, Zhang Y, Hong T, Zhang X, Liu X, Mao C, Yan Y, Koppula P, Cheng W, Sood AK, et al. Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity. Oncogene. 2021;40(20):3533–47.

CAS  PubMed